The Impact of Surgical Trauma-Activated Platelet-Rich Fibrin on Mesenchymal Stromal Cells In Vitro

René D Verboket1, Lea Usov1, Isabell Bohl1

  • 1Department of Trauma Surgery and Orthopaedics, University Hospital, Goethe University Frankfurt, 60590 Frankfurt, Germany.

Cells
|May 27, 2026
PubMed
Abstract

Insights

Surgical trauma-activated platelet-rich fibrin (T-PRF) enhances mesenchymal stromal cell (MSC) metabolic activity and early inflammatory responses. However, T-PRF shows limited osteogenic signaling, suggesting a need for balanced therapeutic strategies.

Area of Science:

  • Regenerative Medicine
  • Biomaterials Science
  • Cell Biology

Background:

  • Platelet-rich fibrin (PRF) is a second-generation platelet concentrate promoting tissue repair.
  • The effects of trauma-activated PRF on mesenchymal stromal cells (MSCs) require further investigation.
  • Understanding these interactions is key for optimizing treatments for severe injuries.

Purpose of the Study:

  • To investigate the systemic effects of surgical trauma-activated PRF on MSCs in vitro.
  • To analyze MSC metabolic activity, inflammatory responses, and regenerative capacity.
  • To optimize advanced treatment concepts for severe fractures and injuries.

Main Methods:

  • PRF membranes were generated from trauma patients (T-PRF) and healthy controls (C-PRF).
  • MSCs were co-incubated with PRF membranes for 24, 72, and 120 hours.
  • Metabolic activity (MTT assay) and gene expression analyses were performed.

Main Results:

  • T-PRF significantly increased MSC metabolic activity at 120 hours.
  • Cytokine levels (CXCL10, IL-6, VEGF, IDO) peaked in the T-PRF group at 72 hours.
  • T-PRF initially stimulated MAPK14 and VEGFA gene expression but decreased RUNX2 expression over time.

Conclusions:

  • Trauma-activated PRF induces early inflammatory and stress responses in MSCs.
  • PRF preserves angiogenic but shows limited osteogenic signaling in MSCs.
  • Optimizing PRF preparation and potentially combining it with immunomodulatory approaches is crucial for therapeutic success.